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a  b  s  t  r  a  c  t
Exposure  of  three  native  IgG1  monoclonal  antibodies  to  100  mM  acetate,  pH 3.5  had  no signiﬁcant  effect
on  their  hydrodynamic  size  (11.5  ± 0.5 nm),  while  elution  from  protein  A with  the  same  buffer  created  a
conformation  of 5.5  ± 1.0  nm.  Formation  of  the  reduced-size  conformation  was  preceded  by  the  known
destabilization  of  the  second  constant  domain  of the  heavy  chain  (C2)  by contact  with  protein  A,
then  compounded  by  exposure  to  low  pH,  creating  extended  ﬂexibility  in  the hinge-C2  region  and
allowing  the Fab  region  to fold  over  the  Fc region.  The  reduced-size  conformation  was necessary  for
complete  elution.  It persisted  unchanged  for at least  7  days  under  elution  conditions.  Physiological
conditions  restored  native  size,  and  it was  maintained  on re-exposure  to 100  mM  acetate,  pH 3.5. ProteingG size
enaturation
efolding
rginine
A-mediated  destabilization  and  subsequent  restoration  of  native  size  did  not  create  aggregates,  but
the  reduced-size  conformation  was  more  susceptible  to  aggregation  by secondary  stress  than  native
antibody.  Protein  A-mediated  formation  of the  reduced-size  conformation  is probably  universal  during
puriﬁcation  of  human  IgG1  antibodies,  and  may  occur  with  other  subclasses  and  IgG  from  other  species,
as well  as Fc-fusion  proteins.
ublis©  2015  The  Authors.  P
. Introduction
Potential negative consequences of exposing IgG to low pH have
ade protein A elution conditions an object of controversy for
ecades. Many investigators have expressed concern that exposure
o low pH causes conformational changes leading to aggregation,
nd they have cited formation of turbidity upon pH neutralization
f protein A elutes as proof [1–13]. Others have favored the hypoth-
sis that IgG conformation is unaffected by such exposure [14,15],
ased on their observation that removal of turbidity by micro-
ltration had negligible effect on antibody recovery. Consistent
ith the latter perspective, a recent study showed that forma-
ion of turbidity was mediated through pH-dependent insolubility
f chromatin-associated host cell contaminants in the eluted IgG
raction [16].
Direct characterization of domain stability with high-resolution
-dimensional NMR  has shown that the second constant domain
C2) of IgG collapses entirely at pH 3.1 [17]. This makes elution
onditions a legitimate concern for afﬁnity chromatography media
hat are commonly eluted in the range of pH 2–3, like protein G and
rotein L [13], but most antibodies elute from protein A at pH 3.5
∗ Corresponding author. Tel.: +65 6407 0941; fax: +65 6478 9561.
E-mail address: pete gagnon@bti.a-star.edu.sg (P. Gagnon).
ttp://dx.doi.org/10.1016/j.chroma.2015.03.080
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unhed  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
or higher, especially on current-generation recombinant protein A
ligands that bind IgG exclusively at the Fc region [18]. NMR  shows
that domain integrity of puriﬁed IgG is virtually unperturbed at pH
3.5 [17].
These ﬁndings create an expectation that protein A afﬁnity
chromatography should be completely benign as a puriﬁcation
method, but the controversy surrounding elution at low pH has
been screening another phenomenon that challenges that conclu-
sion. X-ray crystallography studies have shown that the residence
of protein A in its primary binding site between the C2 and C3
domains creates instability in the C2 domain [19,20]. This suggests
it must also affect IgG conformation during puriﬁcation by pro-
tein A, but there is no standard for extrapolating chromatographic
behavior from protein interactions constrained in a crystal lattice.
The present study addresses the conformation of IgG immediately
following elution from protein A and its subsequent neutralization.
2. Materials and methods
2.1. Reagents and equipmentBuffers, salts, and reagents were obtained from Sigma-Aldrich
(St. Louis, MO), except allantoin, which was  obtained from Merck
Millipore (Darmstadt, Germany). Toyopearl AF-rProtein A-650F
was obtained from Toso Bioscience (Tokyo). UNOsphereTM Q was
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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btained from Bio-Rad Laboratories (Hercules, CA, USA). Capto
dhere was obtained from GE Healthcare (Uppsala, Sweden). Chro-
atography media were packed in XK or TricornTM series columns
GE Healthcare). Chromatography experiments were conducted on
n ÄKTATM Explorer 100 or Avant 25 (GE Healthcare).
.2. Experimental methods
Three prospective biosimilar IgG1 monoclonal antibodies
HerceptinTM, AvastinTM, and HumiraTM) were expressed by mam-
alian cell culture in Chinese hamster ovary (CHO) cells using a
ricistronic vector developed by Ho et al. [21]. They were produced
n 15–30 day fed-batch cultures, harvested at 30–50% cell viability.
IgG used to support most of the study was  highly puriﬁed to
inimize interference with analytical methods. Cell culture har-
est was clariﬁed by adding caprylic acid to cell-free culture harvest
o a ﬁnal concentration of 0.4%, and allantoin to a ﬁnal concentra-
ion of 2%. pH was adjusted to 5.3 with 1 M acetic acid, and the
ixture stirred for 2 h. UNOsphere Q pre-equilibrated with 50 mM
ES, 150 mM NaCl, pH 5.3 was added at a proportion of 5% (v/v) and
ixing continued for at least 4 h. Solids were removed by centrifu-
ation and/or microﬁltration. Protein A afﬁnity chromatography
edia was equilibrated with 50 mM Hepes, 120 mM NaCl, pH 7.0.
ample was loaded and the column washed with 10 column vol-
mes (CV) of equilibration buffer, then eluted with a step to 100 mM
cetic acid, pH 3.5, or the same buffer with NaCl or arginine added.
ggregates, antibody fragments, DNA and residual host cell pro-
eins were further removed by titrating the protein A eluate to pH
.0, adding NaCl to 1 M,  loading it onto Capto adhere, and eluting
ith a step to 50 mM MES, 0.35 M NaCl, pH 6.0. Antibodies puriﬁed
y this process contained <10 ppm host cell protein (HCP), less than
 ppm DNA, and less than 0.1% aggregates. For the remainder of the
iscussion, this material is referred to as highly puriﬁed IgG.
Experimental controls were conducted in some cases with
gG puriﬁed by protein A afﬁnity chromatography where the cell
ulture harvest was clariﬁed only by centrifugation and microﬁl-
ration.
Experimental controls were also conducted in some cases with
ntibody puriﬁed without exposure to protein A. In brief, harvest
as clariﬁed with the caprylate-allantoin-solid phase adsorbent
ystem described above, then fractionated by anion exchange chro-
atography in void exclusion mode (VEAX) [22], in 50 mM Tris, pH
.0. NaCl was  added to the IgG-containing VEAX void fraction to a
nal concentration of 1.0 M then applied to Capto adhere and eluted
s described above..3. Analytical methods
IgG purity was documented according to the methods described
ully in [16]. In brief, host cell protein (HCP) content was  estimated
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by ELISA with a Generation III CHO HCP kit from Cygnus Technolo-
gies Inc. (Southport, NC). DNA was measured using a QX100TM
Droplet DigitalTM PCR System (Bio-Rad Laboratories). Aggregate
content was measured by analytical size exclusion chromatography
(SEC) with a G3000SWxl column (Tosoh Bioscience) on a Dionex
UltimateTM 300 HPLC system (Thermo Scientiﬁc) operated at a
ﬂow rate of 0.6 mL/min, using a buffer formulation of 50 mM MES,
20 mM EDTA, 200 mM arginine, pH 6.0. Sample injection volume
was 100 L.
Solute size distributions in free solution were characterized by
dynamic light scattering (DLS) using a Zetasizer ZS (Malvern Instru-
ments, Worcestershire, UK). The sample (200 L) was mixed gently
for 10 seconds on a vortex before being placed into a quart cuvette
(ZEN2112, Malvern Instruments) using a gel loading tip to avoid
bubbles. Viscosity of the carrier solution was determined using a
SV-10 viscometer (A&D Company, Tokyo). The backscattered light
at 173◦ was  measured and 3 measurements were averaged. Atten-
uation index was maintained at a value of 7–8. Analysis of the data
was performed using version 7.02 of the Dispersion Technology
Software provided by the manufacturer.
Circular dichroism (CD) spectroscopy was performed with a
JASCO J-810 spectropolarimeter (JASCO Corp., Tokyo). Far-UV spec-
tra (190-260 nm) were obtained with highly puriﬁed IgG at a
concentration of 0.2 mg/mL  using a quartz cuvette with a path
length of 0.1 cm. Near-UV spectra (250–350 nm) were obtained
with highly puriﬁed IgG at a concentration of 1.0 mg/mL using a
quartz cuvette with a path length of 1.0 cm.  For both, 32 scans
were accumulated with a scan rate of 100 nm/min and time con-
stant of 0.125 s. All Spectra were corrected by subtracting the buffer
baseline and averaged 32 times. All experiments were conducted at
room temperature. Relative amounts of random coil, -helix, and
-sheet were calculated using K2D2 software [23].
Other experimental details are described or reiterated for clarity
in the following section.
3. Results and discussion
3.1. Size characterization by DLS
DLS indicated hydrodynamic size of the highly puriﬁed
IgG monoclonal antibodies under physiological conditions was
11.5 ± 0.5 nm.  They maintained that size when titrated to pH 3.5.
When highly puriﬁed native antibodies were applied to protein A
and eluted with 100 mM acetic acid, pH 3.5, hydrodynamic size of
the eluted IgG was  5.5 ± 1.0 nm (Fig. 1).Addition of NaCl increased size of the protein A-eluted IgG, as
did increasing pH (Fig. 2). Exposure to physiological conditions
restored native size. Restored antibody maintained native size at
all tested pH values from 3.5 to 8.5, and NaCl concentrations from
ter, nm
pre-protein A
HE, 11.3 nm
HU, 11.5 nm
AV, 11.5 nm
0               100     1000 
A. Protein A-eluted samples still in 100 mM acetate, pH 3.5. HE, HU, and AV refer to
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7ig. 2. Hydrodynamic size of IgG as a function of pH and NaCl concentration. Comp
.5.
 to 200 mM.  Aggregate content before protein A and after size
estoration was ∼0.1% (SEC).
IgG puriﬁed by protein A from harvests clariﬁed only by cen-
rifugation and microﬁltration were signiﬁcantly contaminated
HCP > 2000 ppm, DNA > 10 ppm, aggregates 1.5–2.5%) and caused
LS to give inﬂated size results (Fig. 2, panel 3). This highlights an
mportant experimental control variable and known artifact of DLS.
he intensity of scattered light is proportional to the 6th power
f the solute diameter [24,25]. This causes aggregates to dispro-
ortionately dominate signal and cause overestimation of smaller
olute size. This was veriﬁed experimentally in the present study
ith a puriﬁed IgG solution containing about ∼35% aggregates
SEC). DLS produced a size estimate of 16.8 nm,  versus 11.9 nm for
 preparation of the same antibody containing ∼0.1% aggregates.
This phenomenon has been highlighted as a beneﬁcial feature of
LS for sensitive detection of low-level aggregates in pharmaceu-
ical solutions, but it creates a source of uncontrolled error where
he intent is to characterize native protein in aggregate-containing
olutions. Except for data shown in Fig. 2, panel 3, all DLS results
eported and discussed in this study were therefore based on appli-
ation to protein A of highly puriﬁed IgG preparations containing
ot more than 0.1% aggregates..2. Size characterization by SEC
SEC is widely considered to be complementary to DLS, and typi-
ally provides a valuable dimension of information that DLS cannot.
PA-eluted IgG i
SEC equilibrate
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250
200
150
100
50
0
ig. 3. Non-speciﬁc adsorption of IgG at pH 3.5 to SEC media. The black triangle at ∼21 m
.0.n of protein A-eluted IgG after neutralization, with protein A-eluted IgG still at pH
It permits relative amounts of different solute size classes within a
sample to be estimated with reasonable accuracy because it relies
on UV absorbance instead of scatter. The one exception to the
utility of SEC is when solutes interact non-speciﬁcally with the
chromatography media surface, and the interaction inﬂuences their
elution times [26,27]. This unfortunately proved to be the case with
protein A-eluted IgG still at pH 3.5.
When protein A-eluted IgG still at pH 3.5 was applied to an
SEC column equilibrated with 100 mM acetate, pH 3.5, non-speciﬁc
interactions caused the applied IgG to bind. It never eluted. This
documented a strong tendency for protein A-eluted IgG to asso-
ciate with even a presumed inert surface under elution conditions,
and emphasized the unsuitability of SEC as a corroborative assay
method under such circumstances.
Application of protein A-eluted IgG still at pH 3.5 to an SEC col-
umn  equilibrated with 50 mM  Hepes, pH 7.0 produced a 2-peak
proﬁle, but the ﬁrst peak coincided with elution of the salts from the
applied sample (Fig. 3). This suggested the ﬁrst peak was desorbed
from the column by those salts, and left it impossible to deter-
mine if the two populations were representative of underlying size
differences.
Application of protein A-eluted IgG still at pH 3.5 to an SEC
column equilibrated with 50 mM Hepes, 150 mM NaCl, pH 7.0
produced a 2-peak proﬁle in which the ﬁrst peak eluted in the
same region as native IgG (Fig. 3), but provided no conﬁdence
that the elution time of either peak accurately reﬂected its size.
Given that the antibody was  being buffer exchanged as it passed
n 100 mM Ac, pH 3.5
d to HBS
15.86
.84
20.74
24.03
 time, min
PA-eluted IgG in 100 mM Ac, pH 3.5
SEC equil. 50 mM Hepes, pH 7.0
          20          30 0           10           20          30
in  shows where sample salts begin to elute. HBS; 50 mM Hepes, 150 mM NaCl, pH
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ig. 4. Comparison of CD spectra for native IgG under physiological conditions, nat
hrough the column, it must be understood to have been in a state
f conformational-size transition that would have confounded
enuine size-based fractionation. Non-speciﬁc interactions, severe
mmediately after injection but less after buffer exchange, would
ave imposed another layer of blind variability.
On the positive side, these results highlight a key contribution
f DLS to the study. Since DLS is free of matrix adsorption effects,
t is able to provide insights under conditions that confound SEC
24,25].
.3. Conformational characterization of protein A-eluted IgG
Observation of reduced-size IgG exclusively after elution docu-
ented that protein A mediated the effect. This is consistent with
-ray crystallographic studies showing that contact between pro-
ein A and the Fc region disorders the upper third of C2 to such
n extent that electron densities become too weak to assign coor-
inates to the alpha carbon atoms [19,20]. The effect extends up
hrough most of the hinge region, and laterally includes most of
he adjacent carbohydrate chain.
This provides an important starting point, but it is evident that
reation of the reduced-size conformation must involve a 2-step
athway where the low pH of elution compounds the denaturation
reated by initial IgG contact with protein A. Circular dichroism
CD) spectroscopy conﬁrmed dramatic loss of structure in the
educed-size conformation (Fig. 4). -sheet was reduced 45% com-
ared to native molecule under physiological conditions (from
0.48% to 5.69%), accompanied by a 55% increase of -helix (from
11.5 nm
Native, face
Fab
Fc
hinge
Cγ1
CL
VL
Cγ2
protein A
Cγ3
Vγ
N
Fig. 5. Hypothetical gross-conformation of protein A-eluted, nm
 at pH 3.5, and the reduced-size conformation eluting from protein A at pH 3.5.
36.17% to 56.26%), and 28% reduction of random coil (from 53.35% to
38.05%). Native antibody titrated to pH 3.5 showed weak responses
in the same wavelength ranges where the reduced-size conforma-
tion showed extreme responses, but otherwise tracked closely with
native antibody under physiological conditions.
CD spectra do not deﬁne where the loss of structure occurs, but
other studies highlight C2 as the focal point. C3 becomes disor-
dered at pH 2.0, but not at pH 3.0 [17,28], and X-ray crystallography
data show that C3 is structurally unaffected by its interaction with
protein A [19,20]. Differential scanning calorimetry studies have
shown that rabbit polyclonal IgG folds over on itself at pH 2.0–2.5,
putting the Fab region in direct contact with Fc [29,30]. It seems
logical that the reduced-size conformation of IgG eluted from pro-
tein A likewise represents a folded-over conﬁguration, where the
inherent ﬂexibility of the hinge, augmented by ﬂexibility imposed
by compound denaturation under acidic conditions, permits the
Fab region to come into contact with the C3 domain (Fig. 5).
3.4. Ramiﬁcations for protein A as an afﬁnity chromatography
ligand
The above ﬁndings bear on why  protein A has been so success-
ful as a ligand for afﬁnity chromatography. The denaturation of IgG
by initial contact with protein A conceptually parallels the phe-
nomenon of induced ﬁt in enzyme–substrate systems. IgG is forced
by denaturation into conformance with the chemical topography
of protein A [19,20]. This reconciles how a generally hydropho-
bic electronegative protein ligand (pI  ∼5.1) can offer such reﬁned
ative, side
5.5 nm
Post-protein A
side
 IgG at pH 3.5, showing Fab folded over the Fc region.
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H  3.5.
peciﬁcity, and why its afﬁnity for IgG is so high [31–34]. Another
hromatography-enabling feature of initial contact denaturation
s that it increases sensitivity of C2 to compound denaturation
pon exposure to pH 3.5. This eliminates the need for the more
xtreme elution conditions imposed by other biological afﬁnity lig-
nds, like protein L, protein G, and immunoafﬁnity. It also highlights
n additional parallel with enzyme-substrate systems, in this case
epresenting the phenomenon whereby enzymes reduce the acti-
ation energy required to convert one substrate conformation to
nother.
.5. The effect of eluted IgG size on elution efﬁciency
Other lines of evidence suggest that IgG must be in the reduced-
ize conformation to achieve complete elution. Having shown that
gG size increased as a function of NaCl concentration even at low
H, a series of experiments was conducted in which NaCl was
ncluded at increasing concentrations during elution at pH 3.5. IgG
ecovery decreased dramatically (Fig. 6). IgG that failed to elute
as recovered in a subsequent NaOH wash. Addition of arginine
o elution buffers had the same molar inﬂuence on size as NaCl.
rginine’s impact on IgG recovery was less negative than NaCl, but
till supported the conclusion that the reduced-size conformation
s necessary for complete elution.
The difference in recovery between NaCl and arginine is con-
istent with known features of the interaction between IgG and
rotein A. Most of the binding energy between IgG and protein A is
ydrophobic, and the remainder from four hydrogen bonds [19,20].
aCl is often used to promote protein binding on hydrophobic
nteraction and hydrophobic multimodal chromatography media,
nd would be understood to disfavor dissociation of IgG from pro-
ein A. Arginine has been recommended to enhance elution of IgG
rom protein A, speciﬁcally because it relaxes hydrophobic inter-
ctions [1]. Its guanido residue — a guanidine analog — is also
nown to be a strong hydrogen donor-acceptor. This suggests argi-
ine permitted better recovery than NaCl because its suppression of
ydrogen bonding and hydrophobic interactions partially compen-
ated for the increase in IgG size, versus NaCl, which compounded
he effects of IgG size.We  note a superﬁcial conﬂict between the present data and a
ublished conclusion that arginine enhances elution of IgG from
rotein A through relaxation of hydrophobic interactions [1]. The
uthors relied on peak width as an indicator. We  also observednd IgG recovery. NaCl and arginine added to a foundation buffer of 100 mM acetate,
very substantial narrowing of the elution peak with increasing argi-
nine content, but elution proﬁles indicated it was a function of
higher buffer capacity producing a steeper transition to the end-
point pH. Most discussions of arginine center on the properties of
its guanido residue, but it also carries a carboxyl. At acidic pH, only
the carboxyl groups contribute to buffer capacity. 500 mM arginine-
carboxyls would be understood to increase buffer capacity 6-fold
over 100 mM acetate by itself.
Fig. 7 illustrates these effects. Note especially the relative slopes
of the pH curves. Columns were loaded with 25 mg/mL  highly
puriﬁed IgG, then eluted as discussed, and cleaned with 50 mM
NaOH. The large IgG load caused the elution peaks to saturate the
UV monitor at 280 nm,  causing the peaks to appear broad at the
top. Proﬁles at 254 also suffered from saturation, but to a much
lesser degree that revealed conventionally shaped elution peaks for
acetate and acetate-arginine. The wavelength ratio of 254–280 nm
in the acetate-NaCl elution is typical for IgG and provides a ref-
erence to appreciate the degree of optical distortion by monitor
saturation in the other proﬁles.
3.6. Susceptibility of the reduced-size conformation to
aggregation
Guo et al. [35,36] recently traced the presence of IgG aggregates
to formation of an unstable intermediate conformation created by
contact with a cation exchanger. This invites an expectation that
conformational modiﬁcation of IgG by its interaction with pro-
tein A might also induce aggregation, especially considering that
variations in C2 conformation have been found to correlate with
formation of aggregates in pharmaceutical formulations [17]. Sur-
prisingly, aggregate content of reduced-size IgG neutralized after 7
days at pH 3.5 (and all lesser intervals) was identical to its aggre-
gate content prior to loading the already highly puriﬁed antibody
onto protein A (0.1%).
This provides some comfort that prolonged exposure to low pH
during virus inactivation is unlikely to promote excessive aggre-
gate formation by itself, but it should not be understood to indicate
that the reduced-size conformation is inherently stable. A series
of experiments was performed in which the pH of freshly protein
A-eluted IgG and native IgG were reduced in parallel to pH 3.0,
held for 1 h, then titrated to physiological pH. No aggregate for-
mation was  induced in the native IgG, but extensive aggregation
was observed in the protein A-eluted antibody (Fig. 8). Note also
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he greater IgG peak width that partly obscured the trailing H2L
mpurity (2 heavy chains, 1 light chain). This suggested that even
he non-aggregated IgG population had an elevated tendency to
articipate in non-speciﬁc interactions, which implies a tendency
oward further aggregation over time.
These results underline an important caution about eluting pro-
ein A at pH values below pH 3.5, but their greater signiﬁcance is
heir conﬁrmation of the general phenomenon whereby protein A-
ediated denaturation elevates vulnerability of IgG to aggregation
y secondary stress.
.7. IgG conformation as a puriﬁcation process variableOverall results of the study highlight a ﬁnal point, that IgG con-
ormation following protein A chromatography is a process control
ariable in its own right. It has an impact on recovery of IgG from
rotein A columns, which makes it an economic issue. It has an
Native IgG
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ig. 8. SEC proﬁles illustrating increased vulnerability of protein A-puriﬁed IgG to aggreghe effects of arginine and NaCl in the elution buffer.
impact on aggregate formation, which makes it a process devel-
opment and product quality issue. IgG size can be modulated at
any stage of protein A chromatography by simple modiﬁcations of
buffer content and pH, and its effects measured to guide develop-
ment of the most favorable conditions for any given antibody.
The fact that 3 different human IgG1 monoclonal antibodies
behaved similarly suggests that most antibodies of this species and
subclass will do the same. This conclusion is fortiﬁed by the fact that
the X-ray crystallographic studies originally describing protein A-
mediated denaturation of IgG were performed with Fc fragments
from human polyclonal IgG1. IgG from other species and subclasses,
and the Fc component from fusion proteins, may  undergo sim-
ilar changes, though perhaps to different degrees. NMR  studies
demonstrate that secondary factors such as differential glycosyl-
ation particularly affect C2-mediated aggregation [17]. It seems
reasonable to anticipate that they may  also modulate the degree of
conformational change induced by contact with protein A.
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Puriﬁcation of IgG1 monoclonal antibodies by protein A afﬁnity
hromatography induced a conformational variant with about half
he hydrodynamic size of the native IgG; ∼5.5 nm versus ∼11.5 nm.
D spectroscopy revealed ∼45% loss of -sheet, with a 55% increase
f -helix and 28% reduction of random coil. Formation of the
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as denaturation of the upper third of the C2 domain under
hysiological conditions by its initial contact with protein A, and
he second where low pH elution compounded the denaturation
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olded over in contact with the C3 region. The reduced-size con-
ormation persisted as long as the IgG remained resident in elution
onditions. IgG size increased towards native dimensions with ele-
ation of pH and/or elevation of NaCl concentration, and native
ize was fully restored under physiological conditions. Restored IgG
aintained native size upon re-exposure to pH 3.5.
Elution efﬁciency was highest when IgG was in its most-
educed-size conformation, but fair elution efﬁciency was obtained
ith larger conformations in the presence of additives that weaken
ydrogen bonds and hydrophobic interactions between IgG and
rotein A, such as arginine. Formation of the reduced-size con-
ormation and its subsequent restoration to native size did not
roduce aggregates, but aggregation of the reduced-size conforma-
ion was induced by secondary stress factors, and those aggregates
ersisted after neutralization. Observation of the reduced-size con-
ormation with 3 different IgG1 monoclonal antibodies suggest the
henomenon is probably universal for this human subclass, and
ay occur with other subclasses and species, as well as with Fc
usion proteins.
cknowledgements
The authors gratefully acknowledge the National University of
ingapore for providing access to instrumentation for perform-
ng analysis by CD spectroscopy. We  equally acknowledge Qiaohui
ang and Chiew Ling Lim for their contributions to other aspects
f the analysis; and Han Ping Loh, Su Jun Low, Jake Chng and
uansheng Yang for making the cell cultures available to pro-
uce puriﬁed antibodies for conducting the study. We  equally
cknowledge the generous support of Exploit Technologies Pte.
td., Validated Biosystems, and the Biomedical Research Council
f the Singapore Agency for Science and Technology Research.
eferences
[1] T. Arakawa, J. Philo, K. Tsumoto, R. Yumioka, D. Ejima, Elution of antibodies
from a protein-A column by aqueous arginine solutions, Protein Expr. Purif. 36
(2004) 244–248.
[2] D. Ejima, R. Yumioka, K. Tsumoto, T. Arakawa, Effective elution of antibodies
by  arginine and arginine derivatives in afﬁnity column chromatography, Anal.
Biochem. 345 (2005) 250–257.
[3] T. Arakawa, Y. Kita, K. Tsumoto, D. Ejima, H. Fukada, Aggregation suppression
of  proteins by arginine during thermal unfolding, Protein Pept. Lett. 13 (2006)
921–927.
[4] K. Tsumoto, M.  Umetsu, I. Kumagai, D. Ejima, J. Philo, T. Arakawa, Role of argi-
nine in protein refolding, solubilization, and puriﬁcation, Biotechnol. Progr. 20
(2004) 1301–1308.
[5] T. Arakawa, K. Tsumoto, The effects of arginine on refolding of aggregated pro-
teins: not facilitate refolding, but suppress aggregation, Biochem. Biophys. Res.
Commun. 304 (2003) 148–152.
[6] T. Arakawa, D. Ejima, K. Tsumoto, N. Obeyama, Y. Tanaka, Y. Kita, S. Timash-
eff, Suppression of protein interactions by arginine: a proposed mechanism of
arginine effects, Biophys. Chem. 127 (2007) 1–8.
[7] U. Das, G. Hariprasad, A. Ethayathulias, P. Manral, T. Das, S. Pasha, A. Mann, M.
Gangui, A. Verma, R. Bhat, S. Chandrayan, S. Ahmed, S. Sharma, P. Kaur, T. Singh,
A. Srinivasan, Inhibition of protein aggregation: supramolecular assemblies of
arginine hold the key, PLoS One (2007) e1176.
[. A 1395 (2015) 136–142
[8] B. Baynes, B. Trout, Rational design of solution additives for the prevention of
protein aggregation, Biophys. J. 87 (2004) 1631–1639.
[9] B. Baynes, D. Wang, B. Trout, The role of arginine in the stabilization of proteins
against aggregation, Biochemistry 44 (2005) 4919–4925.
10] C. Sneider, B. Trout, Investigation of cosolute-protein preferential interaction
coefﬁcients: new insight into the mechanism by which arginine inhibits aggre-
gation, J. Phys. Chem. B 113 (2009) 2050–2058.
11] D. Shukla, B. Trout, Interaction of arginine with proteins and the mechanism
by which it inhibits aggregation, J. Phys. Chem. B 114 (2010) 13426–13438.
12] D. Shukla, L. Zamolo, C. Cavallotti, B. Trout, Understanding the role of arginine
as  an eluent in afﬁnity chromatography via molecular computations, J. Phys.
Chem. 115 (2011) 2645–2654.
13] P. Gagnon, Puriﬁcation Tools for Monoclonal Antibodies, Validated Biosystems,
Tucson, 1996.
14] S. Vunnum, G. Vedantham, B. Hubbard, Protein A-based afﬁnity chromatogra-
phy, in: U. Gottschalk (Ed.), Process Scale Puriﬁcation of Antibodies, J. Wiley
and Sons, Hoboken, 2009, pp. 79–102.
15] S. Tobler, A. Noyes, J. Rajewski, R. Shpritzer, W.  Piacenza, J. Coffman, S. Vunnum,
B.  Kelly, Analysis of protein a peak precipitates and approaches to reduce peak
turbidity, in: Poster presented at the ACS Conference, San Francisco, CA, 2006.
16] P. Gagnon, R. Nian, J. Lee, L. Tan, S.M. Abdul Latiff, C.L. Lim, C. Chuah, X. Bi,
Y.S. Yang, W.  Zhang, H.T. Gan, Nonspeciﬁc interactions of chromatin with
immunoglobulin G and protein A, and their impact on puriﬁcation perfor-
mance, J. Chromatogr. A 1340 (2014) 68–78.
17] R. Latypov, S. Hogan, H. Law, H. Gadgil, D. Liu, Elucidation of acid-induced
unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc, J. Biol.
Chem. 287 (2012) 1381–1396.
18] S. Ghose, M.  Allen, B. Hubbard, C. Brooks, S. Cramer, Antibody variable region
interactions with protein A: implications for the development of generic puriﬁ-
cation processes, Biotechnol. Bioeng. 92 (2005) 665–673.
19] J. Deisenhofer, Crystallographic reﬁnement and atomic models of a human Fc
fragment ant its complex with fragment B of protein A from Staphylococcus
aureus at 2.9 and 2.8 A˚ resolution, Biochemistry 20 (1981) 2361–2370.
20] J. Deisenhofer, T. Jones, R. Huber, J. Sjödahl, J. Sjöquist, Crystallization, crystal
structure analysis and atomic model of the complex formed by a human Fc frag-
ment and fragment B of protein A from Staphylococcus aureus, Hoppe-Seylars
Z,  Physiol. Chem. 359 (1978) 975–985.
21] S.C. Ho, M.  Bardor, H. Feng, Y.W. Mariati, Z. Tong, M.G.S. Song, Y.S. Yap, Yang,
IRES-mediated Tricistronic vectors for enhancing generation of high mono-
clonal antibody expressing CHO cell lines, J. Biotechnol. 157 (2012) 130–139.
22] R. Nian, C. Chuah, J. Lee, H.T. Gan, S.M.B. Abdul-Latiff, W.Y. Lee, V. Vagenende, P.
Gagnon, Void exclusion of antibodies by grafted-ligand porous particle anion
exchangers, J. Chromatogr. A 1282 (2013) 127–132.
23] C. Perez-Iratxeta, M.  Andrade-Navarro, K2D2: estimation of protein secondary
structure from circular dichroism spectra, BMC  Struct. Biol. 8 (2005) 25.
24] T. Arakawa, J. Philo, D. Ejima, K. Tsumoto, F. Arisaka, Aggregation analysis of
therapeutic proteins, part 2, analytical ultracentrifugation and dynamic light
scattering, Bioprocess Int. 5 (4) (2007) 36–47.
25] S. Amin, G. Barnett, J. Pathak, C. Roberts, P. Sarangpani, Protein aggregation,
particle formation, characterization & rheology, Curr. Opin. Coll. Interface Sci.
19  (2014) 438–449.
26] K. Stulik, V. Pacakova, M. Ticha, Some potentialities and drawbacks of contem-
porary size-exclusion chromatography, J. Biochem. Biophys. Met. 56 (2003)
1–13.
27] T. Arakawa, D. Ejima, T. Li, J. Philo, The critical role of mobile phase composition
in  size exclusion chromatography of protein pharmaceuticals, J. Pharm. Sci. 99
(2010) 1674–1692.
28] M.  Thies, R. Kammermeier, K. Richter, J. Buchner, The alternatively folded state
of  the antibody CH3 domain, J. Mol. Biol. 309 (2001) 1077–1085.
29] J. Buchner, M.  Renner, H. Lilie, H.J. Hinz, R. Jaenicke, T. Kiefhabel, R. Rudolph,
Alternatively folded states of an immunoglobulin, Biochemistry 30 (1991)
6922–6929.
30] S. Martsev, Z. Krachuk, A. Vlasov, G. Lyakhnovich, Thermodynamic and func-
tional characterization of a stable conformer obtained by renaturation from a
partially structured low pH-induced state, FEBS Lett. 361 (1995) 173–175.
31] I. Björck, B. Petersson, J. Sjöquist, Some physicochemical properties of protein
A  from Staphylococcus aureus,  Eur. J. Biochem. 29 (1972) 579–584.
32] J. Langone, Protein A of Staphylococcus aureus and related immunoglobulin
receptors produced by streptococci and pneumococci, Adv. Immunol. 32 (1982)
157–252.
33] M.  Graille, E. Stura, A. Corper, B. Sutton, M.  Taussig, J.-B. Charbonnier, G. Silver-
man,  Crystal structure of a Staphylococcus aureus protein A domain complexed
with Fab fragment of a human IgM antibody: structural basis for recognition of
B-cell receptors and superantigen activity, Proc. Nat. Acad. Sci. U.S.A. 97 (2000)
5399–5404.
34] J. Sjöquist, B. Meloun, H. Hjelm, Protein A isolated from Staphylococcus aureus
after  digestion with lysostaphin, Eur. J. Biochem. 29 (1972) 572–578.
35] J. Guo, S. Zhang, G. Carta, Unfolding and aggregation of a glycosylated mono-
clonal antibody on a cation exchange column. Part I. Chromatographic elution36] J. Guo, G. Carta, Unfolding and aggregation of a glycosylated monoclonal
antibody on a cation exchange column. Part II. Protein structure effects by
hydrogen deuterium exchange mass spectrometry, J. Chromatogr. A 1356
(2014) 129–137.
